Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer
Yasutaka Yamada(Harvard University), Himisha Beltran(Cornell University)
Cited by 47
Related Papers
Patient derived organoids to model rare prostate cancer phenotypes
|Nature Communications|2018|356
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
|Nature Cancer|2023|109
Aberrantly expressed <scp>PLOD</scp>1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
|Molecular Oncology|2019|62